Finance

Lists
Q2 2026 earnings • released • EPS miss -40.31% • Revenue beat +0.86%
See results
EHTH:NASDAQ
eHealth Inc
$1.37
+1.48%
(+0.020) 1D
Aug 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EHTH...
Open
$1.34
High
$1.43
Low
$1.34
Mkt. cap
43.88M
Avg. vol.
394.69K
Volume
261.33K
52-wk high
$5.89
52-wk low
$1.20
EPS
-$0.62
Beta
1.49
Shares outstanding
32.03M
No. of employees
2K
Open
$1.34
High
$1.43
Low
$1.34
Mkt. cap
43.88M
Avg. vol.
394.69K
Volume
261.33K
52-wk high
$5.89
52-wk low
$1.20
EPS
-$0.62
Beta
1.49
Shares outstanding
32.03M
No. of employees
2K
News stories
From sources across the web
StreetInsider
StreetInsider
·
3 days ago
eHealth (EHTH) Misses Q2 EPS by 36c
About eHealth Inc
CEOFrancis S Soistman Jr
Employees1.66K
Founded1997
Headquarters-
SectorInsurance
Analyst ratings
Based on 5 analysts giving stock ratings to EHTH in the past 3 months
Hold
Buy
0
Hold
5
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for EHTH in the last 3 months.
Highest
Current $1.37
$3.00 (+118.98%)
Average
$2.25 (+64.23%)
Lowest
$1.75 (+27.74%)
Analyst
Recommendation
Action
Price target
Projected
Date
George Hill
Deutsche Bank
Hold
Maintained
$2.00
+46%
08/06/2026
Jonathan Yong
UBS
Hold
Maintained
$1.75
+27.7%
08/05/2026
Adam Klauber
William Blair
Hold
Maintained
-
-
08/04/2026
George Sutton
Craig-Hallum
Hold
Maintained
-
-
06/08/2026
Ben Hendrix
RBC Capital
Hold
Maintained
$3.00
+119%
05/14/2026
Last report
Aug 4, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$1.12 / -$0.80
-40.31%miss
Revenue / Est. (USD)
33.57M / 33.28M
+0.86%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
53.87M
326.24M
88.02M
33.57M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.80M
16.07M
11.34M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
83.13M
183.91M
73.19M
-
Operating expense
94.94M
199.98M
84.52M
-
Total operating expenses
94.94M
199.98M
84.52M
-
Operating income
-41.07M
126.26M
3.49M
-
Other non operating income
78.00K
-1.30M
840.00K
-
EBT including unusual items
-42.93M
121.98M
-6.07M
-
EBT excluding unusual items
-42.48M
121.98M
299.00K
-
Income tax expense
-11.24M
34.80M
-1.36M
-
Effective tax rate
26.18%
28.53%
22.38%
-
Other operating expenses
-
-
-
-
Net income
-31.69M
87.18M
-4.71M
-
Net profit margin
-58.83%
26.72%
-5.36%
-
Earnings per share
-1.31
2.39
-0.37
-1.12
Interest and investment income
900.00K
400.00K
-
-
Interest expense
-2.38M
-3.38M
-4.04M
-
Net interest expenses
-1.48M
-2.98M
-4.04M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-40.62M
126.76M
3.98M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps